Globus Medical, Inc. (GMED)

NYSE: GMED · IEX Real-Time Price · USD
57.31
+0.55 (0.97%)
Jul 7, 2022 12:10 PM EDT - Market open
0.97%
Market Cap 5.83B
Revenue (ttm) 961.31M
Net Income (ttm) 141.95M
Shares Out 101.73M
EPS (ttm) 1.37
PE Ratio 41.83
Forward PE 27.47
Dividend n/a
Ex-Dividend Date n/a
Volume 215,234
Open 56.92
Previous Close 56.76
Day's Range 56.77 - 57.86
52-Week Range 52.60 - 84.23
Beta 1.11
Analysts Buy
Price Target 77.60 (+35.4%)
Earnings Date Aug 3, 2022

About GMED

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspi... [Read more...]

Industry Health Care Equipment & Supplies
IPO Date Aug 3, 2012
CEO David Demski
Employees 2,400
Stock Exchange NYSE
Ticker Symbol GMED
Full Company Profile

Financial Performance

In 2021, Globus Medical's revenue was $958.10 million, an increase of 21.43% compared to the previous year's $789.04 million. Earnings were $149.19 million, an increase of 45.86%.

Financial Statements

Analyst Forecast

According to 20 analysts, the average rating for GMED stock is "Buy." The 12-month stock price forecast is 77.6, which is an increase of 35.40% from the latest price.

Price Target
$77.6
(35.40% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Why Is Globus Medical (GMED) Up 1.7% Since Last Earnings Report?

Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock?

Here's Why Investors Should Retain Globus Medical (GMED) Now

Globus Medical's (GMED) strong international growth and meaningful product launches raise investors' optimism.

Globus Medical (GMED) Completes First Cases With Excelsius3D

Globus Medical's (GMED) Excelsius3D, when combined with ExcelsiusGPS, facilitates greater implant placement accuracy, lowers radiation exposure and reduces operative times.

Globus Medical Announces First Surgeries Using Excelsius3D™

Intraoperative 3D Imaging System Advances Robotic Navigation Spine Surgery Intraoperative 3D Imaging System Advances Robotic Navigation Spine Surgery

Globus Medical (GMED) Q1 Earnings Miss Estimates, Margins Dip

According to Globus Medical (GMED), its Q1 results reflect modest revenue growth against a difficult prior-year comparison, coupled with COVID-related revenue impacts in key countries.

Globus Medical (GMED) Misses Q1 Earnings and Revenue Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of -8.70% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical Reports First Quarter 2022 Results

AUDUBON, Pa., May 10, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the first quarter ended March 31,...

Analysts Estimate Globus Medical (GMED) to Report a Decline in Earnings: What to Look Out for

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Globus Medical (GMED) Stock Fell on Preliminary Q1 Sales Results

Globus Medical's (GMED) Q1 preliminary sales results reflect an increase in procedural volumes along with growth in Enabling Technologies business.

Why Globus Medical Stock Is Sinking Today

The company's CEO unexpectedly resigned.

Globus Medical Issues Softer Outlook For Q1, CEO Resigns

Globus Medical Inc (NYSE: GMED) announced the resignation of President and CEO Dave Demski after nearly 20 years with the company, with the last four and a half years as its CEO.  The Board of Directors...

Globus Medical Schedules First Quarter Earnings Release and Conference Call

AUDUBON, Pa., April 21, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, ...

Globus Medical Reports CEO Transition and Preliminary First Quarter 2022 Sales Results

AUDUBON, Pa., April 21, 2022 (GLOBE NEWSWIRE) --  Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the resignation of President and Chief Executive Officer...

3 Healthcare Stocks That Could Help Set You Up for Life

These stocks are full of growth potential.

Other symbols: LLYSGEN

Here's Why You Should Retain Globus Medical (GMED) Stock Now

Investors are optimistic about Globus Medical's (GMED) better-than-expected results and strength in the U.S. Spine business.

Globus Medical Announces the Expansion of its Share Repurchase Program

AUDUBON, Pa., March 04, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced that its Board of Directors has expanded the Company's sh...

Globus Medical (GMED) Q4 Earnings Top Estimates, Gross Margin Up

Strength in Musculoskeletal Solutions and Enabling Technologies products drove Globus Medical's (GMED) Q4 revenues.

Globus Medical (GMED) Tops Q4 Earnings and Revenue Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of 2.08% and 2.50%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Globus Medical Reports Fourth Quarter and Full Year 2021 Results

AUDUBON, Pa., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ende...

Earnings Preview: Globus Medical (GMED) Q4 Earnings Expected to Decline

Globus Medical (GMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Globus Medical Schedules Fourth Quarter and Full Year 2021 Earnings Release and Conference Call

AUDUBON, Pa., Jan. 27, 2022 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the fourth quarter and full year en...

Omicron Hits Elective MedTechs, 3 Subsectors Likely to Thrive

Here we discuss three major subsectors of MedTech and three constituent stocks, OPCH, GMED and OMCL for which the change in the scenario has opened up enormous growth prospects.

Other symbols: OMCLOPCH

Here's Why You Should Hold on to Globus Medical (GMED) for Now

Investors are optimistic about Globus Medical (GMED), backed by strength in the Enabling Technologies arm and ExcelsiusGPS platforms.

Is Globus Medical a Great Stock to Buy Right Now?

International sales were down in the most recent quarter.

Why Did BofA Securities Give Globus Medical A Double Upgrade?

Enabling tech is likely to continue driving Globus Medical Inc's (NYSE:GMED) market share gains in 2022, according to BofA Securities. The Globus Medical Analyst: Craig Bijou upgraded the rating for Glo...